98%
921
2 minutes
20
Functional dyspepsia (FD) and gastroparesis (GP) are clinically managed as distinct upper gastrointestinal conditions but present with symptoms that are often indistinguishable. FD is a common disorder of gut-brain interaction that negatively impacts quality of life, while GP is considered a rare disease exclusively defined by delayed gastric emptying and symptoms. The degree of overlap between these disorders makes them hard to differentiate in clinical practice, thereby impacting treatment decisions. This review is focused on exploring the similarities and differences between FD and GP to guide clinician management and improve treatment outcomes. A comprehensive literature search was performed and the full texts of eligible articles were retrieved for the extraction of information reported in this review. This summary of evidence supports the hypothesis that GP and FD represent two ends of the same disease spectrum in a major subgroup. Improved understanding of the similarities, differences and overlap is likely to help guide the development of objective biomarkers and better-targeted therapies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770444 | PMC |
http://dx.doi.org/10.1136/egastro-2024-100119 | DOI Listing |
Fr J Urol
September 2025
Department of urology, Maison de Santé Protestante de Bordeaux-Bagatelle, Talence, France; Department of urology, HIA Robert-Picqué, Villenave d'Ornon, France.
Objectives: To evaluate the efficacy and safety of oral phosphodiesterase-5 inhibitors (PDE5Is) in the treatment of erectile dysfunction (ED). Additionally, to compare various PDE5Is and assess their suitability for different patient populations.
Evidence Acquisition: A systematic review of literature published from January 1999 to January 2023 was conducted following the PICOS criteria.
Gastroenterology
August 2025
Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, UK; Academic Department of Gastroenterology, Sheffield Teaching Hospitals, Sheffield, UK. Electronic address:
Background & Aims: Individuals with disorders of gut-brain interaction (DGBI) may experience avoidant/restrictive food intake disorder (ARFID) symptoms. However, extant findings have been limited to specialist neurogastroenterology clinics. We assessed the association between DGBI and ARFID within the adult general population.
View Article and Find Full Text PDFInt J Surg
September 2025
Division of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Background: Functional dyspepsia (FD) is often comorbid with sleep disturbance. Transcutaneous auricular vagal nerve stimulation (taVNS) is a new and non-invasive therapeutic option. This study aimed to investigate its effects and possible mechanisms on FD with sleep disturbance.
View Article and Find Full Text PDFFront Nutr
August 2025
Department of Rehabilitation, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
The pathogenesis of functional dyspepsia (FD) is closely associated with intestinal microecological alterations. Dietary microorganisms, capable of modulating gut microecology and thereby influencing gastrointestinal function, are being explored as a promising therapeutic strategy against FD. However, the precise mechanisms underlying how dietary microbes exert beneficial effects through microecological modulation, along with therapeutic protocols, remain incompletely defined.
View Article and Find Full Text PDFIntern Med
September 2025
Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Objective Specific microRNAs (miRNAs) in patients with functional dyspepsia (FD) and previous Helicobacter pylori (HP) infections have not been elucidated. This study aimed to investigate exosomal miRNAs as potential biomarkers of FD in patients with a previous HP infection using a liquid biopsy. Methods Six patients with FD and six age- and sex-matched healthy controls (HCs) with a previous HP infection were enrolled in the discovery cohort.
View Article and Find Full Text PDF